2018
DOI: 10.1111/cei.13235
|View full text |Cite
|
Sign up to set email alerts
|

Autoantibodies to killer cell immunoglobulin-like receptor 3DL1 in patients with systemic lupus erythematosus

Abstract: Summary A genetic variant of the killer immunoglobulin‐like receptor 3DL1 (KIR3DL1) has been found in patients with systemic lupus erythematosus (SLE). Herein, we investigated the presence of autoantibodies to KIR3DL1 in a cohort of patients with SLE. We tested sera from 28 patients with SLE, 11 patients with rheumatoid arthritis (RA) and 17 healthy control subjects for anti‐KIR3DL1 activity by an enzyme‐linked immunosorbent assay (ELISA) using recombinant KIR3DL1‐enhanced green fluorescent protein (EGFP) and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

1
1
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 31 publications
1
1
0
Order By: Relevance
“…NK cells in lupus patients might had turned hyperactive due to lowered expression of KIR3DL1 accompanied by increased expression of KIR2DL4 on its surface, leading to disease exacerbation. Report on the presence of anti-KIR3DL1 antibodies in the serum of SLE patients 43 suggests a link to the decline in KIR3DL1 + CD56 dim cells in lupus patients in our study. While studying the relationship between oxidative stress and KIRs, we noticed KIR3DL1 + CD56 bright cells associated with oxidative stress levels in the plasma of patients.…”
Section: Discussionsupporting
confidence: 70%
“…NK cells in lupus patients might had turned hyperactive due to lowered expression of KIR3DL1 accompanied by increased expression of KIR2DL4 on its surface, leading to disease exacerbation. Report on the presence of anti-KIR3DL1 antibodies in the serum of SLE patients 43 suggests a link to the decline in KIR3DL1 + CD56 dim cells in lupus patients in our study. While studying the relationship between oxidative stress and KIRs, we noticed KIR3DL1 + CD56 bright cells associated with oxidative stress levels in the plasma of patients.…”
Section: Discussionsupporting
confidence: 70%
“…These data are line with a previous study, which described antibodies reacting with KIR2DL1 or KIR2DL3-receptors in 7 of 30 (23.3%) SLE patients by probing SLE sera for reactivity to E. coli -derived recombinant KIR2DL1 and KIR2DL3 in Western blot (35). A recent study demonstrated autoantibodies to KIR3DL1 in 22 of 28 SLE sera analyzed with ELISA using recombinant KIR3DL1 (36). In addition to confirming the presence of anti-KIR autoantibodies in SLE patients, our data demonstrate that these autoantibodies react with natively folded membrane-bound KIRs expressed on human cells, and that reactivity to KIR2DL2, KIR3DL2, KIR2DS2, KIR2DS4, and KIR2DL4 is also present in SLE patients.…”
Section: Discussionmentioning
confidence: 99%